Patents matching “LTD.”

US 11447498

Fused tetracyclic compounds and uses thereof in medicine

SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

US 11446342

Composite probiotics and use thereof

INFINITUS (CHINA) COMPANY LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

US 11447500

Thienopyridine derivatives and pharmaceutical composition comprising same

Wellmarker Bio Co., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

US 11439597

Formulations of (R)-2-amino-3-phenylpropyl carbamate

AXSOME MALTA LTD. · Granted Sep 13, 2022 · Expires Sep 8, 2042

US 11433013

Peptide for preventing skin damage caused by air pollutants and for anti-aging, and use thereof

CAREGEN CO., LTD. · Granted Sep 6, 2022 · Expires Sep 1, 2042

US 11427581

JAK inhibitor and use thereof

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Aug 30, 2022 · Expires Aug 25, 2042

US 11413301

Composition comprising sea cucumber extract as effective ingredient for preventing and treating Bruch's membrane dysfunction-related disease

Altregen Co., Ltd. · Granted Aug 16, 2022 · Expires Aug 11, 2042

US 11396495

Amine compound for inhibiting SSAO/VAP-1 and use thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 26, 2022 · Expires Jul 21, 2042

US 11395848

Methods and compositions for treating diabetes

Oramed Ltd. · Granted Jul 26, 2022 · Expires Jul 21, 2042

US 11389544

Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11370836

Monoclonal antibody binding to human IL-5, preparation method therefor and use thereof

SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 11365246

Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

CHEMOMAB LTD. · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11365180

Resolution method for axis chiral enantiomers of lesinurad

CHINA RESOURCES SAIKE PHARMACEUTICAL CO., LTD. · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11364227

Sphingosine kinase 2 inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11357710

Solid mask and preparation method therefor

INFINITUS (CHINA) COMPANY LTD. · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11357783

Conjugate of finasteride with peptide

CAREGEN CO., LTD. · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11351266

Conjugate of isotretinoin and peptide

CAREGEN CO., LTD. · Granted Jun 7, 2022 · Expires Jun 2, 2042

US 11339156

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor

MSD R&D (China) Co. Ltd. · Granted May 24, 2022 · Expires May 19, 2042

US 11324760

Solid dispersion of dutasteride, method for preparing the solid dispersion, and pharmaceutical composition including the solid dispersion

KOREA PRIME PHARM CO., LTD. · Granted May 10, 2022 · Expires May 5, 2042

US 11319298

Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor

MSD R&D (China) Co. Ltd. · Granted May 3, 2022 · Expires Apr 28, 2042

US 11306121

Composition for muscle relaxation

CAREGEN CO., LTD. · Granted Apr 19, 2022 · Expires Apr 14, 2042

US 11306115

Aminoglycoside derivatives and uses thereof in treating genetic disorders

ELOXX PHARMACEUTICALS LTD. · Granted Apr 19, 2022 · Expires Apr 14, 2042

US 11291697

Probiotic composition and use thereof

INFINITUS (CHINA) COMPANY LTD. · Granted Apr 5, 2022 · Expires Mar 31, 2042

US 11291681

Method for treating fibrotic liver tissue using Cl-IB-MECA

CAN-FITE BIOPHARMA LTD. · Granted Apr 5, 2022 · Expires Mar 31, 2042